Groundbreaking kidney drug enters human testing phase
Knowledge-focused
Recruiting now
This is the first human study of an experimental oral medication called SK-09, which is being developed for two serious kidney diseases (FSGS and MCD). The trial will test the safety, side effects, and how the drug moves through the body in 72 healthy adult volunteers. Researcher…
Phase: PHASE1 • Sponsor: Consun Pharmaceutical Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC